Euro Medium Term Note Programme

Source: RNS
RNS Number : 1884V
Babcock International Group PLC
03 March 2026
 

3 March 2026

 

 

Babcock International Group PLC

 

Publication of Base Prospectus

 

The following base prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing:

 

The Prospectus dated 3 March 2026 relating to the Babcock International Group PLC £3,000,000,000 Euro Medium Term Note Programme.

 

 

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

 

To view the Prospectus, please paste the following URL into the address bar of your browser:

 

https://www.babcockinternational.com/investors/debt-investors/emtn-programme/

 

A copy of the Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

For further information please contact:

 

Babcock International Group PLC                             

Andrew Gollan                                                Samuel MacGregor

Director of Investor Relations                           Investor Relations Manager

Tel: +44 7936 039 004                                      Tel: +44 7730 753 159

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIJJMFTMTAMBJF